154 related articles for article (PubMed ID: 12798163)
1. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
Parise RA; Ramanathan RK; Hayes MJ; Egorin MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):39-44. PubMed ID: 12798163
[TBL] [Abstract][Full Text] [Related]
2. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Titier K; Picard S; Ducint D; Teilhet E; Moore N; Berthaud P; Mahon FX; Molimard M
Ther Drug Monit; 2005 Oct; 27(5):634-40. PubMed ID: 16175138
[TBL] [Abstract][Full Text] [Related]
3. Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MS.
Iqbal Z; Elliott M; Watson DG; Holyoake T; Jørgensen H
Pak J Pharm Sci; 2011 Jul; 24(3):285-91. PubMed ID: 21715261
[TBL] [Abstract][Full Text] [Related]
4. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the anti-leukemia drug STI571 (Gleevec) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry.
Bakhtiar R; Khemani L; Hayes M; Bedman T; Tse F
J Pharm Biomed Anal; 2002 Jun; 28(6):1183-94. PubMed ID: 12049982
[TBL] [Abstract][Full Text] [Related]
6. High-throughput quantification of the anti-leukemia drug STI571 (Gleevec) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry.
Bakhtiar R; Lohne J; Ramos L; Khemani L; Hayes M; Tse F
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 768(2):325-40. PubMed ID: 11888061
[TBL] [Abstract][Full Text] [Related]
7. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
Miura M; Takahashi N; Sawada K
J Chromatogr Sci; 2011 May; 49(5):412-5. PubMed ID: 21549035
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.
Guetens G; De Boeck G; Highley M; Dumez H; Van Oosterom AT; de Bruijn EA
J Chromatogr A; 2003 Dec; 1020(1):27-34. PubMed ID: 14661754
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
[TBL] [Abstract][Full Text] [Related]
10. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
Zhang M; Moore GA; Fernyhough LJ; Barclay ML; Begg EJ
Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
12. Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.
Parise RA; Ramanathan RK; Zamboni WC; Egorin MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):231-6. PubMed ID: 12450543
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography.
Davies A; Hayes AK; Knight K; Watmough SJ; Pirmohamed M; Clark RE
Leuk Res; 2010 Jun; 34(6):702-7. PubMed ID: 20004471
[TBL] [Abstract][Full Text] [Related]
14. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study.
Bende G; Kollipara S; Movva S; Moorthy G; Saha R
J Chromatogr Sci; 2010; 48(5):334-41. PubMed ID: 20515524
[TBL] [Abstract][Full Text] [Related]
15. Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry.
Guo L; Qi M; Jin X; Wang P; Zhao H
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):280-5. PubMed ID: 16490405
[TBL] [Abstract][Full Text] [Related]
16. New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1721-6. PubMed ID: 19428316
[TBL] [Abstract][Full Text] [Related]
17. Determination of 5-HT receptor antagonists, MEFWAY and MPPF using liquid chromatography electrospray ionization tandem mass spectrometry in rat plasma and brain tissue.
Zheng Z; Lee BH; Choi JY; Ryu YH; Bae MA; Ahn SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():24-9. PubMed ID: 23266361
[TBL] [Abstract][Full Text] [Related]
18. Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.
Guetens G; Prenen H; De Boeck G; Highley M; de Wever I; van Oosterom AT; de Bruijn EA
J Sep Sci; 2006 Feb; 29(3):453-9. PubMed ID: 16544888
[TBL] [Abstract][Full Text] [Related]
19. A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum.
Parise RA; Egorin MJ; Christner SM; Shah DD; Zhou W; Beumer JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1894-900. PubMed ID: 19493708
[TBL] [Abstract][Full Text] [Related]
20. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
